Manufacturers and contract development and manufacturing organizations are developing processes and facilities to meet growing specialty API demand. For decades, APIs, the foundation of the ...

New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical API Manufacturing Global Market Report 2023" - https ...

New York, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical API Manufacturing Global Market Report 2021: COVID ...

Cedarburg Hauser Pharmaceuticals, the Grafton, WI-based contract developer and manufacturer of active pharmaceutical ingredients (API) for the drug industry, will be acquired for $41 million by Albany ...

Efficiency and adaptability are crucial in the ever-evolving manufacturing industry. As manufacturers adopt advanced technologies like IoT, AI, and cloud computing, the need for seamless integration ...

As quality issues have led to drug shortages, Donald Ashley, director of FDA’s Office of Compliance, raised several major concerns on Tuesday with the active pharmaceutical ingredient (API) industry, ...

In his latest article, Ames Gross explores the opportunities for pharma in China's API market. The active pharmaceutical ingredient (API) market in Asia is worth $32.5 billion, and it is growing ...

Eight months after convincing five companies to pay fines to settle antitrust claims, the European Commission has zeroed in on another firm, active pharmaceutical ingredients (API) manufacturer Alchem ...

The US Food and Drug Administration (FDA) on Tuesday released a warning letter sent 27 June to China-based Zhuhai United Laboratories Co. for significant deviations from CGMP for active pharmaceutical ...